It has also been observed that Semaglutide can trigger the production of neutralizing antibodies
Steinert RE, Luscombe-Marsh ND, Little TJ, Standfield S, Otto B, Horowitz M et al
In fact, prior to October 2023, orlistat (Alli, Xenical) was essentially the only weight loss medication that could be used while maintaining FAA medical certification
Hair shedding associated with tirzepatide follows the same pattern seen with other GLP-1 and GIP/GLP-1 receptor agonists: it is driven primarily by rapid weight loss and the nutritional changes that accompany it, not by the drug acting directly on hair follicles
Statistical Data Analysis The data shows some clear patterns: Women faced a 219% higher risk of anxiety symptoms than non-users Young adults aged 18-49 were more likely to experience psychiatric effects People who used the medication longer (180+ days) saw fewer anxiety cases just 2.93 per 1,000 person-years Comparison with Other GLP-1 Medications GLP-1 medications show different patterns in our data
"GLP-1 receptor agonists in MASH: mechanisms and clinical evidence." Alimentary Pharmacology & Therapeutics